Clinical and survival analysis of nasopharyngeal carcinoma with consistently negative Epstein-Barr virus DNA.

Zhi-Gong WeiXiao-Lin HuYan HeHui Guan Jing-Jing WangLing HeXiao-Li MuZhe-Ran LiuRui-Dan LiXing-Chen Peng

Published in: Head & neck (2021)

NPC patients with consistently negative EBV DNA level performed an earlier clinical stage and negative EBV DNA level was related to preferable survival outcomes.

Keyphrases

epstein barr virus
circulating tumor
diffuse large b cell lymphoma
cell free
single molecule
nucleic acid